References
- Bone K., Palmetto Saw. A Critical Review. European J Herbal Med 1999; 4: 15–24
- Cote R J, Skinner E C, Salem C E. The effect of finasteride on the prostate gland in men with elevated serum prostate-specific antigen levels. British J of Cancer 1998; 78: 423–418
- Delos S, Iehle C, Martin P M. Inhibition of the activity of basic 5a-reductase (type I) detected in DU 145 cells and expressed in insect cells. J Steroid Biochem. Molec. Biol. 1994; 48: 247–352
- Iehle C, Delos S, Guirou O. Human prostatic steroid 5a-reductase isoforms-A comparative Study of Selective Inhibitors. J Steroid Biochem. Molec. Biol. 1995; 54: 273–279
- Carraro J C, Raynaud J P, Koch G. Comparison of phytotherapy (permixon) with finasteride in the treatment of benign prostate hyperplasia: A randomized international study of 1,098 patients. The Prostate 1996; 29: 231–240
- Shaneyfelt T, Husein R, Bubley G. Hormonal predictors of prostate cancer: A meta-analysis. J Clin. Oncol. 2000; 18: 847–853
- Weisburger J H. International symposium on lycopene and tomato products in disease prevention: An Introduction. Proc. Exp. Bio. Med. 1998; 218: 299–306
- Ohno Y, Yoshida O, Oishi K. Dietary beta-carotene and cancer of the prostate: A case control study in Kyoto, Japan. Cancer Res. 1988; 48: 1331–1336
- Chew B, Park J, Wong M. A comparison of the anticancer activities of dietary beta-carotene, canthaxanthin and astaxanthin in mice in vivo. Anticancer Research 1999; 19: 1849–1854
- Woodall A G, Britton G, Jackson M. Carotenoids and protection of phospholipids in solution or in liposomes against oxidation by peroxyl radicals: Relationship between carotenoid structure and protective ability. Biochim. Biophys. Acta. 1997; 1336: 575–586
- Milon A, Wolff G, Nakatani Y. Organic carotenoid-phospholipid bilayer systems. Incorporation of zeaxanthin, astaxanthin and their C50 homologous dimyri-stoylphosphatidylcholine vesicles. Helv. Chemica. 1986; 69: 12–24
- Tanaka T, Morishita Y, Suzui M. Chemoprevention of mouse urinary bladder carcinogenesis by the naturally occurring carotenoid astaxanthin. Carcinogenesis 1994; 15: 15–19
- Tanaka T, Kawamori T, Ohnishi M. Suppression of azomethane-induced rat colon carcinogenesis by dietary administration of naturally occurring xanthophylls astaxanthin and canastaxanthin during the postinitiation phase. Carcinogenesis 1995; 16: 2957–2963
- Tanaka T, Makita H, Ohnishi M. Chemoprevention of rat oral carcinogenesis by naturally occurring xanthophylls astaxanthin and canastaxanthin. Cancer Res. 1995; 55: 4059–4064